BCIQ Profiles

Company Profile Report
0914 Fin QTs
BioCentury & Getty Images


Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more 

Sep 15, 2020 | 1:33 AM GMT

Escient raises $77.5M B round
Escient Pharmaceuticals Inc. announced Monday the start of a Phase I/Ib trial of lead program EP547 for cholestatic and

Read the full 491 word article

How to gain access

Continue reading with a
two-week free trial.